HURVITZ CHAIM purchased 14.0% of their position (70K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $20.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/11/2023ACC: 0001415889-23-013137
+70K
Net shares
Net buyer
$20.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
70K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Direct
Shares
+70K
Price / share
$0.29
Trade value
$20.13K
% of position
14.0%
8/30/2023
500K→570K
Total
Net shares
+70K
Net value
$20.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 8/30/2023 | P · Purchase | +70K | $0.29 | $20.13K | 14.0% | 500K | 570K |
| Total | +70K | $20.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, par value $0.001 per share
IndirectShares owned1.44M
Common Stock, par value $0.001 per share
IndirectShares owned208.44K
Total
1.64M indirect1.64M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 1.44M | Indirect |
| Common Stock, par value $0.001 per share | 208.44K | Indirect |
| Total | 1.64M | 1.64M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported